Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 223,807,811 papers from all fields of science
Search
Sign In
Create Free Account
Peak Nasal Inspiratory Flow
Known as:
PNIF
The maximal flow achieved during the maximally forced inspiration through the nose initiated at maximum exhalation.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
CDISC SDTM Respiratory Test Name Terminology
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The determining factors of peak nasal inspiratory flow and perception of nasal airflow in asthmatics.
W. M. Thorstensen
,
Malcolm Sue-Chu
,
V. Bugten
,
M. Cvancarova
,
S. Steinsvåg
Rhinology
2014
Corpus ID: 195676450
BACKGROUND The effect of pulmonary pathology on peak nasal inspiratory flow (PNIF) remains largely unknown. We investigated an…
Expand
2011
2011
Reference values for peak nasal inspiratory flow in children and adolescents in Brazil.
C. daCunhaIbiapina
,
C. RibeirodeAndrade
,
Moreira Camargos Pa
,
C. GoncalvesAlvim
,
A. AugustoCruz
2011
Corpus ID: 203779633
STATEMENT OF THE PROBLEM Allergic rhinitis is a global public health issue. Peak nasal inspiratory flow (PNIF) can help in the…
Expand
Highly Cited
2006
Highly Cited
2006
Desloratadine therapy for symptoms associated with perennial allergic rhinitis.
Kenneth T. Kim
,
G. Sussman
,
J. Hébert
,
W. Lumry
,
B. Lutsky
,
D. Gates
Annals of Allergy, Asthma & Immunology
2006
Corpus ID: 46627771
2005
2005
Evaluation of an intranasal house dust mite provocation model as a tool in clinical research
N. B. Oldenbeuving
,
A. KleinJan
,
+4 authors
W. Fokkens
Allergy. European Journal of Allergy and Clinical…
2005
Corpus ID: 24810155
Background: As a result of the all‐year‐round exposure to house dust mite (HDM), perennial rhinitis patients never have a clear…
Expand
2004
2004
Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis
D.K.C. Lee
,
M. Gardiner
,
K. Haggart
,
S. Fujihara
,
B. Lipworth
Clinical and Experimental Allergy
2004
Corpus ID: 22801248
Background There are no data directly comparing the relative efficacy of modern H1‐antihistamines in allergic rhinitis using…
Expand
2004
2004
A placebo‐controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis
D.K.C. Lee
,
R. Gray
,
F. Robb
,
S. Fujihara
,
B. Lipworth
Clinical and Experimental Allergy
2004
Corpus ID: 12992020
Background There are presently no placebo‐controlled data regarding the effects of butterbur (BB) on subjective and objective…
Expand
Highly Cited
2003
Highly Cited
2003
Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen…
D. Spangler
,
M. Abelson
,
A. Ober
,
Paulo J Gotnes
Clinical Therapeutics
2003
Corpus ID: 12365711
2002
2002
Increased nasal mucosal swelling in subjects with asthma
J. Hellgren
,
K. Torén
,
B. Balder
,
M. Palmqvist
,
O. Löwhagen
,
G. Karlsson
Clinical and Experimental Allergy
2002
Corpus ID: 34143522
Objective The objective of this study was to evaluate nasal mucosal swelling with acoustic rhinometry in subjects with asthma and…
Expand
1991
1991
Peak nasal inspiratory flow and Wright peak flow: a comparison of their reproducibility.
R. Enberg
,
D. Ownby
Annals of allergy
1991
Corpus ID: 34614282
The measurement of peak nasal inspiratory flow (PNIF) is a rapid, convenient, and objective way to assess nasal patency. It is…
Expand
1988
1988
PNIF Owner Attitudes in the Midwest: A Case Study in Missouri and Wisconsin
Timothy D. Marty
,
W. Kurtz
,
J. Gramann
1988
Corpus ID: 92537690
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required